Cibus, Inc. Logo

Cibus, Inc.

Develops & licenses gene-edited, non-transgenic traits to the seed industry for resilient crops.

CBUS | US

Overview

Corporate Details

ISIN(s):
US13173L1070 (+1 more)
LEI:
Country:
United States of America
Address:
6455 NANCY RIDGE DRIVE, 92121 SAN DIEGO
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

Cibus, Inc. is an agricultural biotechnology company that develops and licenses plant traits to the seed industry. The company utilizes a proprietary, high-throughput precision gene-editing technology to create specific, value-added traits in a non-transgenic manner, significantly accelerating the development timeline compared to traditional breeding. Cibus focuses on creating more resilient and sustainable crops by developing traits that provide herbicide tolerance, disease resistance, and pest resistance. Its business model involves partnering with seed companies to integrate these traits into major crops like canola, soybean, and wheat, generating revenue through licensing agreements and royalties.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Cibus, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Cibus, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Cibus, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

PULSE BIOSCIENCES, INC. Logo
Developing nsPFA bioelectric tech for precise, non-thermal tissue ablation in cardiology.
United States of America
PLSE
Q32 Bio Inc. Logo
Clinical-stage biotech developing biologic therapies for autoimmune and inflammatory diseases.
United States of America
QTTB
QinetiQ Group PLC Logo
Global defence & security firm providing tech solutions, test & evaluation for government clients.
United Kingdom
QQ
Qualigen Therapeutics, Inc. Logo
A clinical-stage company developing innovative treatments for rare cancers in adults and children.
United States of America
QLGN
Quanterix Corp Logo
Offers an ultra-sensitive immunoassay platform for biomarker analysis in research and diagnostics.
United States of America
QTRX
Develops uncopiable atomic fingerprints for anti-counterfeiting, verifiable by smartphone.
United Kingdom
QUBE
QUANTUM BLOCKCHAIN TECHNOLOGIES PLC Logo
R&D firm using AI and quantum computing to create efficient technologies for Bitcoin mining.
United Kingdom
QBT
QUIA PHARMA AB Logo
Develops biobetters by enhancing approved drugs with a patented drug delivery platform.
Sweden
QUIA
Qurient Co., Ltd. Logo
Biopharma developing novel drugs for cancer, inflammation, and infectious diseases.
South Korea
115180
Radiopharm Theranostics Ltd Logo
Developing first-in-class radiopharmaceuticals for the diagnosis and treatment of cancer.
United States of America
RADX

Talk to a Data Expert

Have a question? We'll get back to you promptly.